Effects of rosuvastatin on the metabolism of apolipoprotein B of VLDL1, VLDL2, IDL and LDL during type 2 diabetes

被引：0
|
作者：
Verges, B. [1 ]
Florentin, E. [2 ]
Baillot-Rudoni, S.
Monnier, S. [2 ]
Petit, J. M.
Gambert, P. [2 ]
Duvillard, L. [2 ]
机构：
[1] Complexe Hosp Bocage, Dijon, France
[2] Ctr Hosp Univ, INSERM, Cri 866, Dijon, France
来源：
DIABETES & METABOLISM | 2008年 / 34卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
O94
引用
收藏
页码：A37 / A37
页数：1
相关论文
共 50 条
  • [41] ABNORMAL HEPATIC APOLIPOPROTEIN B METABOLISM IN TYPE 2 DIABETES
    Verges, B.
    ATHEROSCLEROSIS SUPPLEMENTS, 2009, 10 (02)
  • [42] Increased LDL apolipoprotein B oxidation in IGT and overt type 2 diabetes
    Julius, UA
    Pietzsch, J
    DIABETES, 2004, 53 : A231 - A231
  • [43] 2 APOLIPOPROTEIN-B GENE DEFECTS IN A KINDRED WITH HYPOBETALIPOPROTEINEMIA, ONE OF WHICH RESULTS IN A TRUNCATED VARIANT, APO-B-61, IN VLDL AND LDL
    PULLINGER, CR
    HILLAS, E
    HARDMAN, DA
    CHEN, GC
    NAYAVIGNE, JM
    IWASA, JA
    HAMILTON, RL
    LALOUEL, JM
    WILLIAMS, RR
    KANE, JP
    JOURNAL OF LIPID RESEARCH, 1992, 33 (05) : 699 - 710
  • [44] SH2B1 and SH2B2 in the Liver Regulate Hepatic Lipid Metabolism and VLDL Secretion
    Sheng, Liang
    Zhou, Yingjiang
    Rui, Liangyou
    DIABETES, 2013, 62 : A485 - A485
  • [45] LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes
    Wägner, AM
    Jorba, O
    Rigla, M
    Alonso, E
    Ordóñez-Llanos, J
    Pérez, A
    ACTA DIABETOLOGICA, 2002, 39 (04) : 215 - 220
  • [46] LDL-cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes
    A.M. Wägner
    O. Jorba
    M. Rigla
    E. Alonso
    J. Ordóñez-Llanos
    A. Pérez
    Acta Diabetologica, 2002, 39 : 215 - 220
  • [47] VLDL triglyceride accumulation in skeletal muscle and adipose tissue in type 2 diabetes
    Sondergaard, Esben
    Nielsen, Soren
    CURRENT OPINION IN LIPIDOLOGY, 2018, 29 (01) : 42 - 47
  • [48] Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus
    A. Hiukka
    E. Leinonen
    M. Jauhiainen
    J. Sundvall
    C. Ehnholm
    A. C. Keech
    M. R. Taskinen
    Diabetologia, 2007, 50 : 2611 - 2613
  • [49] Reduction of large VLDL particles by fenofibrate is associated with reduction of small dense LDL in type 2 diabetes: Field Helsinki substudy
    Hiukka, A.
    Leinonen, E.
    Hilden, H.
    Perttunen-Nio, H.
    Keech, A.
    Taskinen, M. R.
    ATHEROSCLEROSIS SUPPLEMENTS, 2006, 7 (03) : 359 - 360
  • [50] Long-term effects of fenofibrate on VLDL and HDL subspecies in participants with type 2 diabetes mellitus
    Hiukka, A.
    Leinonen, E.
    Jauhiainen, M.
    Sundvall, J.
    Ehnholm, C.
    Keech, A. C.
    Taskinen, M. R.
    DIABETOLOGIA, 2007, 50 (10) : 2067 - 2075
12345